Literature DB >> 1845151

Enzyme replacement therapy in type I Gaucher disease.

A C Kay1, A Saven, P Garver, D W Thurston, B F Rosenbloom, E Beutler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845151

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN: 0066-9458


× No keyword cloud information.
  4 in total

1.  Alglucerase for Gaucher's disease: dose, costs and benefits.

Authors:  E Beutler; A M Garber
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981

Review 2.  Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

Review 3.  Substrate reduction therapy in mouse models of the glycosphingolipidoses.

Authors:  Frances M Platt; Mylvaganam Jeyakumar; Ulrika Andersson; Tanya Heare; Raymond A Dwek; Terry D Butters
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

Review 4.  Curious Cases of the Enzymes.

Authors:  Nuriye Nuray Ulusu
Journal:  J Med Biochem       Date:  2015-07-14       Impact factor: 3.402

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.